Age-related Macular Degeneration Information
What is age-related macular degeneration?
Age-related macular degeneration (AMD) is a
disease that blurs the sharp, central vision you
need for "straight-ahead" activities such as
reading, sewing, and driving. AMD affects the
macula, the part of the eye that allows you to see
fine detail. (See diagram below.)
AMD causes no pain.
In some cases, AMD advances so slowly that people
notice little change in their
visual
acuity. In others, the
disease progresses faster and may lead to a loss of
vision in both eyes. AMD is a leading cause of
vision loss in Americans 60 years of age and older.
| Where is the
macula? The macula is a small, highly
sensitive area located in the center of the
retina, the light-sensitive tissue at the
back of the eye. The retina instantly
converts light, or an image, into electrical
impulses. The retina then sends these
impulses, or nerve signals, to the brain
where they are interpreted as an image.
Are there different forms of AMD?
AMD occurs in two forms: wet and dry. |

|
|
Illustration
by JirehDesign.com |
What is wet AMD?
Wet AMD occurs when abnormal blood vessels behind
the retina start to grow under the macula. These
new
blood vessels tend to be very fragile and often leak
blood and fluid. The blood and fluid raise the
macula from its normal place at the back of the eye.
Damage to the macula occurs rapidly.
With wet AMD, loss of central vision can occur
quickly. Wet AMD is considered to be advanced AMD
and is more severe than the dry form.
An early symptom of wet AMD is that straight
lines appear wavy. If you notice this condition or
other changes to your vision, contact your eye care
professional at once. You need a comprehensive
dilated eye exam.
What is dry AMD?
Dry AMD occurs when the light-sensitive cells in
the macula slowly break down, gradually blurring
central vision in the affected eye. As dry AMD gets
worse, you may see a blurred spot in the center of
your vision. Over time, as less of the macula
functions, central vision in the affected eye can be
lost gradually.
The most common symptom of dry AMD is slightly
blurred vision. You may have difficulty recognizing
faces. You may need more light for reading and other
tasks. Dry AMD generally affects both eyes, but
vision can be lost in one eye while the other eye
seems unaffected.
One of the most common early signs of dry AMD is
drusen. Drusen are yellow deposits under the
retina.
They often are found in people over age 60. Your eye
care professional can detect drusen during a
comprehensive
dilated eye exam.
Dry AMD has three stages, all of which may occur
in one or both eyes:
- Early AMD. People with early AMD have either
several small
drusen or a few medium-sized
drusen. At this stage, there are no symptoms and
no vision loss.
- Intermediate AMD. People with intermediate
AMD have either many medium-sized
drusen or one
or more large drusen. Some people see a blurred
spot in the center of their vision. More light
may be needed for reading and other tasks.
- Advanced Dry AMD. In addition to
drusen,
people with advanced dry AMD have a breakdown of
light-sensitive cells and supporting tissue in
the central retinal area. This breakdown can
cause a blurred spot in the center of your
vision. Over time, the blurred spot may get
bigger and darker, taking more of your central
vision. You may have difficulty reading or
recognizing faces until they are very close to
you.
If you have vision loss from dry AMD in one eye
only, you may not notice any changes in your overall
vision. With the other eye seeing clearly, you still
can drive, read, and see fine details. You may
notice changes in your vision only if AMD affects
both eyes. If blurriness occurs in your vision, see
an eye care professional for a comprehensive
dilated
eye exam.

Normal vision |
|

The same scene as viewed by a
person with age-related macular degeneration |
Do drusen cause vision loss in advanced dry AMD?
Drusen alone do not usually cause vision loss. In
fact, scientists are unclear about the connection
between drusen and AMD. They do know that an
increase in the size or number of drusen raises a
person's risk of developing either advanced dry AMD
or wet AMD. These changes can cause serious vision
loss.
The dry form has early and intermediate stages.
Does the wet form have similar stages?
No. The wet form is considered advanced AMD.
Can advanced AMD be either the dry form or the
wet form?
Yes. Both the wet form and the advanced dry form
are considered advanced AMD. Vision loss occurs with
either form. In most cases, only advanced AMD can
cause vision loss.
People who have advanced AMD in one eye are at
especially high risk of developing advanced AMD in
the other eye.
Which is more common--the dry form or the wet
form?
The dry form is much more common. More than 85
percent of all people with intermediate and advanced
AMD combined have the dry form.
However, if only advanced AMD is considered,
about two-thirds of patients have the wet form.
Because almost all
visual acuity loss comes from advanced
AMD, the wet form leads to significantly more vision
loss than the dry form.
Can the dry form turn into the wet form?
Illustration
by JirehDesign.com
Yes. All people who have the wet form had the dry
form first.
The dry form can advance and cause vision loss
without turning into the wet form. The dry form also
can suddenly turn into the wet form, even during
early stage AMD. There is no way to tell if or when
the dry form will turn into the wet form.
Who is at risk for AMD?
AMD can occur during middle age. The risk
increases with aging. Other risk factors include:
- Smoking.
- Obesity. Research studies suggest a link
between obesity and the progression of early and
intermediate stage AMD to advanced AMD.
- Race. Whites are much more likely to lose
vision from AMD than African Americans.
- Family history. People with a family history
of AMD are at higher risk of getting the
disease.
- Gender. Women appear to be at greater risk
than men.
How is AMD detected?
AMD is detected during a comprehensive eye exam
that includes:
-
Visual acuity test. This eye chart test
measures how well you see at various distances.
Dilated eye exam. Drops are placed in your
eyes to widen, or dilate, the
pupils. Your eye
care professional uses a special magnifying lens
to examine your
retina and optic nerve for signs
of AMD and other eye problems. After the exam,
your close-up vision may remain blurred for
several hours.
Your eye care professional also may do other
tests to learn more about the structure and health
of your eye.
During an eye exam, you may be asked to look at
an Amsler grid. The pattern of the grid resembles a
checkerboard. You will cover one eye and stare at a
black dot in the center of the grid. While staring
at the dot, you may notice that the straight lines
in the pattern appear wavy. You may notice that some
of the lines are missing. These may be signs of AMD.
(See Amsler grid.)
If your eye care professional believes you need
treatment for wet AMD, he or she may suggest a
fluorescein angiogram. In this test, a special dye
is injected into your arm. Pictures are taken as the
dye passes through the blood vessels in your retina.
The test allows your eye care professional to
identify any leaking blood vessels and recommend
treatment.
How is dry AMD treated?
Once dry AMD reaches the advanced stage, no form
of treatment can prevent vision loss. However,
treatment can delay and possibly prevent
intermediate AMD from progressing to the advanced
stage, in which vision loss occurs. The National Eye
Institute's Age-Related Eye Disease Study (AREDS)
found that taking a specific high-dose formulation
of antioxidants and zinc significantly reduces the
risk of advanced AMD and its associated vision loss.
Slowing AMD's progression from the intermediate
stage to the advanced stage will save the vision of
many people.
What is the dosage of the AREDS formulation?
The specific daily amounts of antioxidants and
zinc used by the study researchers were 500
milligrams of vitamin C, 400 International Units of
vitamin E, 15 milligrams of beta-carotene (often
labeled as equivalent to 25,000 International Units
of vitamin A), 80 milligrams of zinc as zinc oxide,
and two milligrams of copper as cupric oxide. Copper
was added to the AREDS formulation containing zinc
to prevent copper deficiency anemia, a condition
associated with high levels of zinc intake.
Who should take the AREDS formulation?
People who are at high risk for developing
advanced AMD should consider taking the formulation.
You are at high risk for developing advanced AMD if
you have either:
1. Intermediate AMD in one or both eyes.
OR
2. Advanced AMD (dry or wet) in one eye but not
the other eye.
Your eye care professional can tell you if you
have AMD, its stage, and your risk for developing
the advanced form.
The AREDS formulation is not a cure for AMD. It
will not restore vision already lost from the
disease. However, it may delay the onset of advanced
AMD. It may help people who are at high risk for
developing advanced AMD keep their vision.
Can people with early stage AMD take the AREDS
formulation to help prevent the disease from
progressing to the intermediate stage?
There is no apparent need for those diagnosed
with early stage AMD to take the AREDS formulation.
The study did not find that the formulation provided
a benefit to those with early stage AMD. If you have
early stage AMD, a comprehensive
dilated eye exam
every year can help determine if the disease is
progressing. If early stage AMD progresses to the
intermediate stage, discuss taking the formulation
with your doctor.
Can diet alone provide the same high levels of
antioxidants and zinc as the AREDS formulation?
No. The high levels of vitamins and minerals are
difficult to achieve from diet alone. However,
previous studies have suggested that people who have
diets rich in green leafy vegetables have a lower
risk of developing AMD.
Can a daily multivitamin alone provide the same
high levels of antioxidants and zinc as the AREDS
formulation?
No. The formulation's levels of antioxidants and
zinc are considerably higher than the amounts in any
daily multivitamin.
If you are already taking daily multivitamins and
your doctor suggests you take the high-dose AREDS
formulation, be sure to review all your vitamin
supplements with your doctor before you begin.
Because multivitamins contain many important
vitamins not found in the AREDS formulation, you may
want to take a multivitamin along with the AREDS
formulation. For example, people with osteoporosis
need to be particularly concerned about taking
vitamin D, which is not in the AREDS formulation.
How is wet AMD treated?
There are two treatments for wet AMD: laser
surgery and photodynamic therapy. Neither treatment
is a cure for wet AMD. Each treatment may slow the
rate of vision decline or stop further vision loss.
The disease and loss of vision may progress despite
treatment.
- Laser surgery. This procedure uses a laser
to destroy the fragile, leaky blood vessels. A
high energy beam of light is aimed directly onto
the new blood vessels and destroys them,
preventing further loss of vision. However,
laser treatment also may destroy some
surrounding healthy tissue and some vision. Only
a small percentage of people with wet AMD can be
treated with laser surgery. Laser surgery is
more effective if the leaky blood vessels have
developed away from the
fovea, the central part
of the macula. (See illustration
at the beginning of this document.) Laser
surgery is performed in a doctor's office or eye
clinic.
The risk of new blood vessels developing
after laser treatment is high. Repeated
treatments may be necessary. In some cases,
vision loss may progress despite repeated
treatments.
-
Photodynamic therapy. A drug called
verteporfin is injected into your arm. It
travels throughout the body, including the new
blood vessels in your eye. The drug tends to
"stick" to the surface of new blood vessels.
Next, a light is shined into your eye for about
90 seconds. The light activates the drug. The
activated drug destroys the new blood vessels
and leads to a slower rate of vision decline.
Unlike laser surgery, this drug does not destroy
surrounding healthy tissue. Because the drug is
activated by light, you must avoid exposing your
skin or eyes to direct sunlight or bright indoor
light for five days after treatment.
Photodynamic therapy is relatively painless. It
takes about 20 minutes and can be performed in a
doctor's office.Photodynamic therapy slows
the rate of vision loss. It does not stop vision
loss or restore vision in eyes already damaged
by advanced AMD. Treatment results often are
temporary. You may need to be treated again.
What can I do if I already have lost some vision
from AMD?
If you have lost some sight from AMD, don't be
afraid to use your eyes for reading, watching TV,
and other routine activities. Normal use of your
eyes will not cause further damage to your vision.
If you have lost some sight from AMD, ask your
eye care professional about
low vision services and
devices that may help you make the most of your
remaining vision. Ask for a referral to a specialist
in low vision. Many community organizations and
agencies offer information about low vision
counseling, training, and other
special services for
people with visual impairments. A nearby school of
medicine or optometry may provide low vision
services.
What research is being done?
The National Eye Institute is conducting and
supporting a number of studies to learn more about
AMD.
For example, scientists are:
- Studying the possibility of transplanting
healthy cells into a diseased retina.
- Evaluating families with a history of AMD to
understand genetic and hereditary factors that
may cause the disease.
- Looking at certain anti-inflammatory
treatments for the wet form of AMD.
This research should provide better ways to
detect, treat, and prevent vision loss in people
with AMD.
What can I do to protect my vision?
- Dry AMD. If you have dry AMD, you should
have a comprehensive
dilated eye exam at least
once a year. Your eye care professional can
monitor your condition and check for other eye
diseases. Also, if you have intermediate AMD in
one or both eyes, or advanced AMD in one eye
only, your doctor may suggest that you take the
AREDS formulation containing the high levels of
antioxidants and zinc.
Because dry AMD can turn into wet AMD at any
time, you should get an Amsler grid from your
eye care professional. Use the grid every day to
evaluate your vision for signs of wet AMD. This
quick test works best for people who still have
good central vision. Check each eye separately.
Cover one eye and look at the grid. Then cover
your other eye and look at the grid. If you
detect any changes in the appearance of this
grid or in your everyday vision while reading
the newspaper or watching television, get a
comprehensive
dilated eye exam.
- Wet AMD. If you have wet AMD and your doctor
advises treatment, do not wait. After laser
surgery or photodynamic therapy, you will need
frequent eye exams to detect any recurrence of
leaking blood vessels. Studies show that people
who smoke have a greater risk of recurrence than
those who don't. In addition, check your vision
at home with the Amsler grid.
If you detect any changes, schedule an eye exam
immediately.
|
.
Here is what
an Amsler grid
normally looks |

This is how an Amsler grid
might look to someone with AMD. |
Can my lifestyle make a difference?
Your lifestyle can play a role in reducing your
risk of developing AMD.
- Eat a healthy diet high in green leafy
vegetables and fish.
- Don't smoke.
- Maintain normal blood pressure.
- Watch your weight.
- Exercise.
What should I ask my eye care professional?
You can protect yourself against vision loss by
working in partnership with your eye care
professional. Ask questions and get the information
you need to take care of yourself.
What are some questions to ask?
About my eye disease or disorder...
- What is my diagnosis?
- What caused my condition?
- Can my condition be treated?
- How will this condition affect my vision now
and in the future?
- Should I watch for any particular symptoms
and notify you if they occur?
- Should I make any lifestyle changes?
About my treatment...
- What is the treatment for my condition?
- When will the treatment start and how long
will it last?
- What are the benefits of this treatment and
how successful is it?
- What are the risks and side effects
associated with this treatment?
- Are there foods, drugs, or activities I
should avoid while I'm on this treatment?
- If my treatment includes taking medicine,
what should I do if I miss a dose?
- Are other treatments available?
About my tests…
- What kinds of tests will I have?
- What can I expect to find out from these
tests?
- When will I know the results?
- Do I have to do anything special to prepare
for any of the tests?
- Do these tests have any side effects or
risks?
- Will I need more tests later?
Other suggestions
- If you don't understand your eye care
professional's responses, ask questions until
you do understand.
- Take notes or get a friend or family member
to take notes for you. Or, bring a tape recorder
to help you remember the discussion.
- Ask your eye care professional to write down
his or her instructions to you.
- Ask your eye care professional for printed
material about your condition.
- If you still have trouble understanding your
eye care professional's answers, ask where you
can go for more information.
- Other members of your health care team, such
as nurses and pharmacists, can be good sources
of information. Talk to them, too.
Today, patients take an active role in their
health care. Be an active patient about your eye
care.
The National Eye Institute (NEI), part of
the National Institutes of Health (NIH), is
the Federal government's principal agency
for conducting and supporting vision
research. Inclusion of an item in this
publication does not imply the endorsement
by the NEI or the NIH or The Macula Center.
Related links:
Macular Degeneration and Nutrition
Macular Degeneration
procedures and surgeries
Macular Degeneration
Research
Drusen and Dry Macular
Degeneration
The effects
of antioxidants on the eye and retina
Macular
Degeneration and Gene Therapy
Cigarette
Smoking and Macular Degeneration
Vision loss
is expensive
New Success
Data on Lucentis for macular degeneration
Lutein reduces risk of
macular degeneration
Obesity and Eye Health
Obesity and
smoking can accelerate AMD
Retina health
vitamins
Cataract
surgery does not complicate AMD
Some
information courtesy of the National Eye Institute |